Legacy Edge Advisors LLC bought a new position in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 5,538 shares of the company's stock, valued at approximately $1,265,000. A number of other hedge funds